Evaluating factors affecting outcomes after catheter ablation for atrial fibrillation
The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study
This study looks at how different factors like age and sex affect whether atrial fibrillation comes back after patients have a catheter ablation treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3100 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Yonsei University Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT02138695 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify clinical factors associated with the recurrence of atrial fibrillation after catheter ablation. It will explore various characteristics such as age, sex, and imaging results to develop a predictive model for clinical outcomes. The study seeks to enhance understanding of how different variables influence the efficacy of catheter ablation in patients with symptomatic, drug-refractory atrial fibrillation.
Who should consider this trial
Good fit: Ideal candidates are patients with symptomatic, drug-refractory atrial fibrillation who are undergoing catheter ablation.
Not a fit: Patients with permanent atrial fibrillation, significant valvular disease, or those under 19 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient selection and outcomes for those undergoing catheter ablation for atrial fibrillation.
How similar studies have performed: Previous studies have shown that catheter ablation can be more effective than drug therapy, but this specific multifactorial approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who undergoing catheter ablation of atrial fibrillation due to symptomatic, drug refractory atrial fibrillation Exclusion Criteria: * patients who do not agree with study inclusion * permanent AF refractory to electrical cardioversion * AF with valvular disease ≥ grade 2 * patients with left atrial diameter greater than 60mm * patients with age less than 19
Where this trial is running
Seoul
- Severance Hospital — Seoul, South Korea (Recruiting)
Study contacts
- Study coordinator: Hui-Nam Pak, MD
- Email: hnpak@yuhs.ac
- Phone: 82-2-2228-8459
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.